CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,458 | +23.2% | 76,178 | +52.4% | 0.24% | +29.3% |
| Q2 2023 | $2,807 | +228.3% | 49,998 | +164.5% | 0.18% | +211.9% |
| Q1 2023 | $855 | -99.6% | 18,904 | +512.8% | 0.06% | +268.8% |
| Q3 2022 | $202,000 | -31.3% | 3,085 | -34.1% | 0.02% | -11.1% |
| Q1 2022 | $294,000 | +35.5% | 4,680 | +63.4% | 0.02% | +50.0% |
| Q4 2021 | $217,000 | -28.1% | 2,865 | +6.1% | 0.01% | -33.3% |
| Q3 2021 | $302,000 | -28.4% | 2,700 | +3.6% | 0.02% | -30.8% |
| Q2 2021 | $422,000 | +40.7% | 2,605 | +5.9% | 0.03% | +30.0% |
| Q1 2021 | $300,000 | -19.8% | 2,460 | +0.8% | 0.02% | -23.1% |
| Q4 2020 | $374,000 | +79.8% | 2,440 | -2.0% | 0.03% | +62.5% |
| Q3 2020 | $208,000 | – | 2,490 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |